SCHEMBL12810892

SCHEMBL12810892

C=Cc1ccc(N2NNN=C2c2cccnc2NC(C)(C)C)c(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425424 0.61 KCNN4 (0.44) —
SCHEMBL1425298 0.59 KCNN4 (0.46) —
SCHEMBL1425971 0.57 KCNN4 (0.38) —
SCHEMBL983904 0.57 KCNN4 (0.50) —
SCHEMBL982800 0.56 KCNN4 (0.46) —
SCHEMBL26665711 0.56 RAB9A (0.37) —
SCHEMBL4560912 0.54 RAB9A (0.53) —
SCHEMBL31039477 0.54 RAB9A (0.53) —
SCHEMBL21284326 0.54 KDM4E (0.36) —
SCHEMBL14184980 0.54 GAA (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205589-B1 C-MET PROTEIN KINASE INHIBITORS VERTEX PHARMA (US) 2011-03-23 — — EP disclosed
Send feedback